Peter Sankey
3 Papers
2 Citations
Peter Sankey is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters.
Jack W. London,Elnara Fazio-Eynullayeva,Matvey B. Palchuk,Peter Sankey,Christopher McNair +4 more
- 27 Jul 2020
TL;DR: The steep decreases in cancer screening and patients with a new incidence of cancer suggest the possibility of a future increase in patients with later-stage cancer being seen initially as well as an increased demand for cancer screening procedures as delayed tests are rescheduled.
PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
Julia Murray,Clare Cruickshank,Thomas Bird,P Bell,J. Braun,David Chuter,Miguel Reis Ferreira,Clare Griffin,Shama Hassan,Nabil M. A. Hujairi,Alan Melcher,Elizabeth Miles,O. Naismith,Miguel Panades,Lara H Philipps,Alison Reid,Jan Rekowski,Peter Sankey,John Staffurth,Isabel Syndikus,Alison Tree,Anna Wilkins,Emma Hall +22 more
TL;DR: PEARLS as mentioned in this paper is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation.
8
PEARLS: Is Our Use of Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography Meaningful for Our Patients?
TL;DR: Prostate-specific membrane antigen positron emission tomography-computed tomography (PSMA PET-CT) is emerging as the most promising and sensitive imaging modality for prostate cancer as mentioned in this paper .
3